Agilent Technologies (A) – Business Wire
-
Agilent Receives Scientists' Choice Awards for Sustainability
-
Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
-
Agilent Brings Great Science to Life at Analytica 2024
-
Agilent at AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics
-
Agilent and UC San Diego Launch Center of Excellence in Cellular Intelligence
-
Agilent Launches New Advanced Dilution System to Increase Lab Efficiency
-
Agilent Presents 2024 Darlene Solomon Award to University of Cambridge Researcher Joycelyn Tan
-
Crawford & Company Reports 2023 Fourth Quarter and Full Year Results Achieved Record Revenues for Year
-
Agilent Presents Solutions Innovation Research Awards to Drexel University and Prairie View A&M University Researchers
-
Agilent Reports First-Quarter Fiscal Year 2024 Financial Results
-
Agilent Announces Cash Dividend of 23.6 Cents per Share
-
Agilent CEO Mike McMullen to Retire; Agilent CrossLab Group President Padraig McDonnell Named CEO-Elect
-
Agilent Ranked Among Top 50 Most Just Companies in America
-
Agilent Wins Two Scientists’ Choice Awards for Drug Discovery and Development Products
-
Agilent to Participate in TD Cowen Health Care Conference
-
Agilent Announces Collaboration with Incyte to Develop Advanced Companion Diagnostics in Hematology and Oncology
-
Agilent to Announce First-Quarter Fiscal Year 2024 Financial Results Feb. 27
-
Agilent Announces New ProteoAnalyzer System
-
Agilent Named to Dow Jones Sustainability Indices for Ninth Consecutive Year
-
Agilent Makes Strategic Updates to Organizational Structure
-
Agilent to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Agilent Again Named “Global Lighthouse” by World Economic Forum for Manufacturing Innovations
-
Agilent Resolve Raman Receives Multiple Recognitions for HazMat and CBRN Excellence
-
Agilent BioTek Cytation C10 Confocal Imaging Reader Enhanced with Innovative Water Immersion Technology
-
Agilent Reports Fourth-Quarter Fiscal Year 2023 Financial Results
-
Agilent to Present at the Evercore ISI HealthCONx Conference
-
Agilent Increases Cash Dividend to 23.6 Cents per Share
-
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
-
Agilent Announces Thought Leader Award to Professor Jennifer Field
-
Crawford & Company Reports 2023 Third Quarter Results
-
Fred R. Donner Elected to Crawford & Company® Board of Directors
-
Crawford & Company Board Declares Dividends
-
Agilent to Announce Fourth-Quarter Fiscal Year 2023 Financial Results Nov. 20
-
Agilent’s Net-Zero Emissions Targets Approved by the Science Based Targets Initiative
-
Helzberg Diamonds Introduces New Demi-fine Collection Scout & Lark
-
Agilent Announces Cash Dividend of 22.5 Cents Per Share
-
Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience
-
Agilent Names Philip Binns to Lead Life Sciences and Applied Markets Group
-
Agilent Receives European IVDR Certification for Companion Diagnostic Assay
-
Agilent Reports Third-Quarter Fiscal Year 2023 Financial Results
-
Agilent 2023 Early Career Professor Award Presented to Ajit Divakaruni
-
Agilent Announces Thought Leader Award to Peter Neubauer
-
Agilent’s 2022 ESG Report Shows Progress Helping Customers Reach Their Sustainability Goals
-
Agilent to Announce Third-Quarter Fiscal Year 2023 Financial Results Aug. 15
-
Helzberg Diamonds Selects Zillion to Help Advance Its Digital Centric Strategy
-
Agilent Achieves Great Place to Work® Certification
-
Agilent Announces Gen6 Software for BioTek Line of Microplate Readers
-
Agilent Innovation Again Recognized with Multiple Scientists' Choice Awards
-
Crawford & Company® to Present During the 13th Annual East Coast IDEAS Conference
-
Agilent Introduces New Comprehensive GPC/SEC Solutions at HPLC 2023 Conference
Back to A Stock Lookup